Skip to main content

GG 337 125 (Levothyroxine Sodium 125 mcg (0.125 mg))

Pill with imprint GG 337 125 is Beige, Capsule-shape and has been identified as Levothyroxine Sodium 125 mcg (0.125 mg). It is supplied by Sandoz Pharmaceuticals Inc..

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 125 mcg (0.125 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 337 125

Levothyroxine sodium 125 mcg (0.125 mg) GG 337 125
Levothyroxine sodium 125 mcg (0.125 mg) GG 337 125 Front
Levothyroxine sodium 125 mcg (0.125 mg) GG 337 125 Back
Levothyroxine sodium 125 mcg (0.125 mg) GG 337 125
Levothyroxine sodium 125 mcg (0.125 mg) GG 337 125

Levothyroxine Sodium

Imprint
GG 337 125
Strength
125 mcg (0.125 mg)
Color
Beige
Size
9.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Thyroid drugs
Pregnancy Category
A - Studies show no risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC)
00781-5186
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, silicon dioxide, sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "GG 337 125"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.